Skip to content

A clinical study to see the effect of two ayurvedic drugs naimly katamkateryadi kwath and phalatrikadi kwath in the 60 patients of prameha (Diabetes)

An open randomized comparative clinical study of katamkateryadi kwath and phalatrikadi kwath in management of prameh with special refernce to hyperglycemia in type 2 diabetes mellitus - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076585
Enrollment
60
Registered
2024-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Chandrakant Ramchandra Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients in the age group of 20 years to 70 years. 2.Sex – Male and Female. 3.Subject who are willing to give written informed consent. 4.BSL - Fasting - 110 mg/dl to 180 mg/dl Post prandial - 140 mg/dl to 280 mg/dl

Exclusion criteria

Exclusion criteria: 1.Patients on insulin therapy. 2.Patient having H/O Diabetic ketoacidosis. 3.Patients with Nephropathy and who are on Immunosuppressant medication. 4.Pregnant women and lactating mother.

Design outcomes

Primary

MeasureTime frame
Blood Sugar Level Fasting and post prandialTimepoint: 60 days

Secondary

MeasureTime frame
1.Prabhut Mutrata 2.Avil Mutrata 3.Pipasa Adhikya 4.Ati kshudha 5.Ati nidra 6.Alasya 7.Kara-pada daha 8.Kara-pada suptata 9.KlamaTimepoint: 60 days

Countries

India

Contacts

Public ContactDr Anaya Pathrikar

APMs Ayurved Mahavidyalaya sion Mumbai

anayapathrikar@gmail.com9870214595

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026